How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Transurethral Resection Of The Prostate Market
- By Procedure Type: Monopolar Transurethral Resection of the Prostate (M-TURP), Bipolar Transurethral Resection of the Prostate (B-TURP), Laser-Assisted Transurethral Resection of the Prostate
- By Indication: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Bladder Outlet Obstruction
- By End-User: Hospitals, Ambulatory Surgical Centers, Urology Clinics
- By Technology: Electrosurgical Devices, Laser Devices, Imaging and Navigation Systems
- By Patient Age Group: 50-60 years, 61-70 years, 71 years and above
Top segment
Monopolar Transurethral Resection of the Prostate (M-TURP) XX% share · $X,XXXM
In the full report →
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Monopolar Transurethral Resection of the Prostate (M-TURP) leads By Procedure Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 12 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 275 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.171 →
- 12 Company Profiles 12 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the Transurethral Resection Of The Prostate Market report
A complete, evidence-based study - 12 chapters and 115 sections covering market size, segmentation across 5 axes, regional analysis and 12 company profiles, forecast to 2033.
Segmentation covered
Procedure Type 3
Indication 3
End-User 3
Technology 3
Patient Age Group 3
Companies profiled
Olympus Corporation
Boston Scientific Corporation
Stryker Corporation
Richard Wolf GmbH
Karl Storz SE & Co. KG
Medtronic plc
B. Braun Melsungen AG
Cook Medical
ConMed Corporation
Smith & Nephew plc
Teleflex Incorporated
Richard Wolf Medical Instruments Corporation
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
12 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Olympus Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Richard Wolf GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Karl Storz SE & Co. KG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Medtronic plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Cook Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →ConMed Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Smith & Nephew plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Teleflex Incorporated
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Richard Wolf Medical Instruments Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,365M by 2033 · 8.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Monopolar Transurethral Resection of the Prostate (M-TURP)59.9
- Bipolar Transurethral Resection of the Prostate (B-TURP)16.6
- Laser-Assisted Transurethral Resection of the Prostate23.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$727.5M → $1,377M · 8.3%
Europe$507.0M → $951.0M · 8.2%
Asia Pacific$462.9M → $906.2M · 8.8%
Latin America$286.6M → $550.3M · 8.5%
Middle East and Africa$220.4M → $483.8M · 10.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.872026
8.872027
8.882028
8.912029
8.912030
8.932031
8.932032
8.962033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Olympus Corporation15.1
- Boston Scientific Corporation23.5
- Stryker Corporation6.8
- Richard Wolf GmbH8.6
- Karl Storz SE & Co. KG8.5
- Medtronic plc9.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Procedure Type23.7%
Indication16.1%
End-User21.9%
Technology21.7%
Patient Age Group16.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.3
- Europe22.3
- Asia Pacific21.2
- Latin America12.9
- Middle East and Africa11.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Olympus Corporation | 97 | 74 | 83 | 77 | 91 | 96 | 86 |
| Boston Scientific Corporation | 87 | 69 | 93 | 91 | 82 | 69 | 82 |
| Stryker Corporation | 77 | 68 | 72 | 73 | 68 | 79 | 73 |
| Richard Wolf GmbH | 62 | 59 | 59 | 67 | 66 | 60 | 62 |
| Karl Storz SE & Co. KG | 70 | 71 | 75 | 62 | 71 | 63 | 69 |
| Medtronic plc | 71 | 68 | 48 | 70 | 62 | 65 | 64 |
| B. Braun Melsungen AG | 60 | 63 | 63 | 50 | 61 | 65 | 60 |
| Cook Medical | 48 | 59 | 40 | 42 | 39 | 55 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Olympus Corporation
- Boston Scientific Corporation
- Stryker Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Olympus Corporation | ✓ | ✓ | ◐ | ◐ | ◐ | ✓ |
| Boston Scientific Corporation | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Stryker Corporation | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Richard Wolf GmbH | − | ◐ | ◐ | ◐ | ✓ | ◐ |
| Karl Storz SE & Co. KG | − | ✓ | ✓ | ◐ | ◐ | ✓ |
| Medtronic plc | − | − | − | ◐ | ◐ | − |
| B. Braun Melsungen AG | ◐ | − | ◐ | − | ◐ | ✓ |
| Cook Medical | − | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Olympus Corporation86
2Boston Scientific Corporation82
3Stryker Corporation73
4Karl Storz SE & Co. KG69
5Medtronic plc64
6Richard Wolf GmbH62
7B. Braun Melsungen AG60
8Cook Medical47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Olympus CorporationBoston Scientific Corporation
Challenger2
Strong scale, closing on the leaders.
Stryker CorporationKarl Storz SE & Co. KG
Contender3
Focused players with pockets of strength.
Richard Wolf GmbHMedtronic plcB. Braun Melsungen AG
Niche1
Specialists in a single segment or region.
Cook Medical
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Procedure Type in North America, then scale across Transurethral Resection Of The Prostate Market — a $331M beachhead inside a $5.38B market.
Beachhead (SOM)$331Mobtainable near-term
Serviceable (SAM)$2.05Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Monopolar Transurethral Resection of the Prostate (M-TURP)
Best fit — highest urgency & budget in Procedure Type.
Economic buyer78 fit
Bipolar Transurethral Resection of the Prostate (B-TURP)
Strong fit — clear ROI and a fast path to value.
End user65 fit
Laser-Assisted Transurethral Resection of the Prostate
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Procedure Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Indication & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Procedure Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Transurethral Resection Of The Prostate Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified22%
Evaluation12%
Closed-won6%
$16.8KCAC
$94KLTV
5.6:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Transurethral Resection Of The Prostate Market is a durable-growth opportunity — $9.22B by 2033, compounding at 7.8%.
TAM · 2025$5.05Btoday
TAM · 2033$9.22Bforecast
CAGR7.8%2027–2033
Cumulative$62.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.22BTotal addressable market
SAM$3.66BServiceable available market
SOM$654MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.8% CAGR
Demand compounds through 2033, outpacing GDP across Procedure Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Procedure Type moving from early to mainstream — durable secular demand.
Consolidation upside
12+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.22BLarge & growingTAM by 2033 at 7.8% CAGR
$3.66BServiceable nowreachable with today’s model
$654MBeachhead winobtainable near-term share
12+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.19BBear5.1% CAGR
$9.22BBase7.8% CAGR
$11.8BBull10.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Indication optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Transurethral Resection Of The Prostate Market — a $4.09B market by 2033. Plan: grow share from 9.9% to 15.7%.
Market size · 2033$4.09Btotal addressable
Market CAGR8.7%2027–2033
Target share15.7%from 9.9% today
Revenue ambition$642Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.9% | 15.7% | On track |
| Revenue | $402M | $642M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 30.0% | 43.9% | Ahead |
| Customer retention | 90.8% | 93.8% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Procedure Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Indication capability
A defensible second engine — invest in Indication to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Procedure Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Indication
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $80M capacity & capability investment
- Greenlight bolt-on M&A in Indication
- Authorise North America expansion plan
- Fund R&D program for Procedure Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Transurethral Resection Of The Prostate Market conversation — a $3.07B market you can size, segment and defend in minutes.
Market size · 2033$3.07Btotal opportunity
Growth7.8%CAGR to 2033
Addressable buyers1,666+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Procedure Type
Goal Grow share in Procedure Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 3 mopayback period
$49K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
12+players profiled in this market
Coverage includes
Olympus CorporationBoston Scientific CorporationStryker CorporationRichard Wolf GmbHKarl Storz SE & Co. KGMedtronic plcB. Braun Melsungen AGCook Medical+4 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Transurethral Resection Of The Prostate Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Transurethral Resection Of The Prostate Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Transurethral Prostatic Resection Device Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportTransurethral Irrigation Catheters Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportTransurethral Flexible Surgical Robot Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportTranstympanic Injectable Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportTranstympanic Delivery System Market
Market size, share, segmentation and regional forecast.
$726M market · 2025 base year
View reportTransthyretin Stabilizer Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportTransthyretin Amyloidosis Treatment Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportTransthyretin Amyloidosis Drug Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportTransthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market
Market size, share, segmentation and regional forecast.
$445M market · 2025 base year
View reportTransseptal Guiding Sheath Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportTransseptal Guiding Introducer Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportTransseptal Delivery Systems Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.